Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420080 · ClinicalTrials.gov registry record
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Terminated
- Registry status
- 100
- Enrollment target
NCT02420080: Clinical Trial study, sponsored by Jazz Pharmaceuticals.
NCT02420080 is a clinical trial that was terminated before completion, run by Jazz Pharmaceuticals. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02420080 was terminated before completion, sponsored by Jazz Pharmaceuticals.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The objective is data collection to determine background rates of adenovirus (AdV) progression and mortality in subjects with Adenovirus (AdV) infection and/or disease.
Primary Outcome
Time to progression of AdV disease through Week 36 post initial AdV diagnosis, with progression of AdV disease defined as time to the occurrence of either clinical progression to probable or definitive disseminated AdV disease or Death.
Interventions
- DRUG Brincidofovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-09 |
Why NCT02420080 stopped before completion
NCT02420080 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Brincidofovir is the first listed.
NCT02420080 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02420080 about?
NCT02420080 is a clinical study titled "A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304". The objective is data collection to determine background rates of adenovirus (AdV) progression and mortality in subjects with Adenovirus (AdV) infection and/or disease.
What is the current status of trial NCT02420080?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2015-02. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02420080?
The interventions under investigation include: Brincidofovir (DRUG).
Who is sponsoring clinical trial NCT02420080?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia